Literature DB >> 2862940

Role of putative neurotransmitters in the central gastric antisecretory effect of prostaglandin E2 in rats.

J Puurunen.   

Abstract

The role of putative neurotransmitters of the central nervous system in the central gastric antisecretory effect of prostaglandin E2 (PGE2) was investigated in pylorus-ligated rats. Pretreatment of the rats with an intracerebroventricular (i.c.v.) injection of 6-hydroxydopamine (6-OHDA) prevented the antisecretory effect of the i.c.v. administration of PGE2, whereas pretreatment with 5,6-dihydroxytryptamine (5,6-DHT) plus p-chlorophenylalanine (PCPA) had no effect. I.c.v.-administered phentolamine and idazoxan antagonized the inhibition of gastric secretion induced by i.c.v. PGE2, whereas prazosin, propranolol and sulpiride injected via the same route were ineffective. Diphenhydramine, cimetidine, naloxone and theophylline, all administered i.c.v., did not modify the antisecretory effect of i.c.v. PGE2. The results suggest that an activation of alpha 2-adrenoceptors in the brain is involved in the central gastric antisecretory effect of PGE2, whereas neither central 5-hydroxytryptamine receptors, alpha 1- or beta-adrenoceptors, D2-dopamine receptors, histamine or opioid receptors nor adenosine seem to play any role here.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862940      PMCID: PMC1916785          DOI: 10.1111/j.1476-5381.1985.tb08849.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Brain regulation of gastric acid secretion in rats by neurogastrointestinal peptides.

Authors:  Y Taché; W Vale; J Rivier; M Brown
Journal:  Peptides       Date:  1981       Impact factor: 3.750

2.  CNS mediated inhibition of gastric secretion by bombesin: independence from interaction with brain catecholaminergic, and serotoninergic pathways and pituitary hormones.

Authors:  Y Taché; R Collu
Journal:  Regul Pept       Date:  1982-01

Review 3.  Adenosine receptors: targets for future drugs.

Authors:  J W Daly
Journal:  J Med Chem       Date:  1982-03       Impact factor: 7.446

4.  Prostacyclin-induced hypothermia: involvement of central histamine H2-receptors.

Authors:  S B Kandasamy; W G Kirlin; P N Kaul
Journal:  Life Sci       Date:  1981-06-01       Impact factor: 5.037

5.  Effects of prostaglandin E2 on brain levels of GABA in mice.

Authors:  R P Rosenkranz; R Thayer; K F Killam
Journal:  Proc West Pharmacol Soc       Date:  1980

6.  The effect of prostaglandin E1 on acetylcholine release from the cat brain.

Authors:  L G Hársing; P Illés; S Fürst; E S Vizi; J Knoll
Journal:  Acta Physiol Acad Sci Hung       Date:  1979

7.  Central inhibition of basal pancreatic and gastric secretions by beta-endorphin in rats.

Authors:  C Rozé; M Dubrasquet; J Chariot; C Vaille
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

8.  Prostaglandins E2 and F2 alpha and acetylcholinesterase activity in the slices of some structures in the cat's brain.

Authors:  L Grbović; B Z Radmanović
Journal:  Arch Int Physiol Biochim       Date:  1981-11

9.  The effect of prostaglandins (PGE2 and PGF2 alpha) on food intake in rats.

Authors:  A S Levine; J E Morley
Journal:  Pharmacol Biochem Behav       Date:  1981-11       Impact factor: 3.533

Review 10.  Physiological and morphological changes in the gastrointestinal tract induced by hypothalamic intervention: an overview.

Authors:  C V Grijalva; E Lindholm; D Novin
Journal:  Brain Res Bull       Date:  1980       Impact factor: 4.077

View more
  2 in total

1.  Stimulation of central alpha-2 adrenoceptors inhibits gastric secretion in rats by releasing vasopressin.

Authors:  J Puurunen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

2.  Effect of gastric secretagogues on the formation of inositol phosphates in isolated gastric cells of the rat.

Authors:  J Puurunen; U Schwabe
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.